Strata Critical Medical (SRTA) Stock Statistics & Valuation Metrics

Strata Critical Medical has a market cap or net worth of $451.67M. The enterprise value is $397.41M.

Strata Critical Medical has 86,526,570 shares outstanding. The number of shares has decreased by -2.65% in one year.

Strata Critical Medical’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -3.20%.

The current PE Ratio of Strata Critical Medical is 35.7. Strata Critical Medical’s PEG ratio is 0.55.

In the last 12 months, Strata Critical Medical had revenue of 197.14M and earned -15.65M in profits. Earnings per share was 0.50.

In the last 12 months, operating cash flow was -40.81M and capital expenditures -13.18M, giving a free cash flow of -53.99M billion.

Strata Critical Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Strata Critical Medical upcoming earnings date is Aug 11, 2026, After Close (Confirmed).

Strata Critical Medical as a current ratio of 6.38, with Debt / Equity ratio of 1.56%

In the past 12 months, Strata Critical Medical has paid 0.00 in taxes.

Strata Critical Medical EV to EBITDA ratio is -126.92, with an EV/FCF ratio of -6.16.

Strata Critical Medical has $58.79M in cash and marketable securities with $4.47M in debt, giving a net cash position of $54.32M billion.

Gross margin is 20.52%, with operating margin of -4.97%, and net profit margin of -7.94%.

The average price target for Strata Critical Medical is $9.17, which is 11.43% higher than the current price. The consensus rating is Strong Buy